Atlas Trials

Study of Everolimus as Maintenance Therapy for Metastatic NEC With Pulmonary or Gastroenteropancreatic Origin

Clinical trial NCT02687958 · UNKNOWN

Trial details

NCT number
NCT02687958
Sponsor
Gruppo Oncologico Italiano di Ricerca Clinica
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Neuroendocrine Carcinoma
Start date
2015-05-01
Primary completion
2022-12-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.